Evidence with Antiplatelet Therapy and ADP-Receptor Antagonists

Publisher： Karger

E-ISSN： 1421-9786|16|1|20-26

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.16, Iss.1, 2003-05, pp. : 20-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Beyond platelet inhibition: potential pleiotropic effects of ADP-receptor antagonists

By Iyengar Srinivas   Rabbani LeRoy  

Journal of Thrombosis and Thrombolysis, Vol. 27, Iss. 3, 2009-04 ,pp. : 300-306

Springer Publishing Company

Access to resources Recommend Favorite

Benefit of ADP Receptor Antagonists in Atherothrombotic Patients: New Evidence

By  

Cerebrovascular Diseases, Vol. 11, Iss. 2, 2001-04 ,pp. : 5-10

Karger

Access to resources Recommend Favorite

Future Prospects in Anti-Platelet Therapy: A Review of Potential P2Y12 and Thrombin Receptor Antagonists

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 3, Iss. 3, 2008-11 ,pp. : 194-200

Bentham Science Publishers

Access to resources Recommend Favorite

Rapid and reversible modulation of platelet function in man by a novel P2Y12 ADP-receptor antagonist, INS50589

By Johnson Fred L.   Boyer José L.   Leese Philip T.   Crean Christopher   Krishnamoorthy Ramesh   Durham Todd   Fox Anthony W.   Kellerman Donald J.  

Platelets, Vol. 18, Iss. 5, 2007-08 ,pp. : 346-356

Informa Healthcare

Access to resources Recommend Favorite

Monitoring antiplatelet therapy with point-of-care platelet function assays: a review of the evidence

By van Werkum Jochem W   Hackeng Christian M   Smit Jaap-Jan J   van’’t Hof Arnoud WJ   Verheugt Freek WA   ten Berg Jurriëën M  

Future Cardiology, Vol. 4, Iss. 1, 2008-01 ,pp. : 33-55

Future Medicine

Access to resources Recommend Favorite